Skip to main content
Year archive

Saniona — 2020 filings

All 91 regulatory filings released by Saniona (SANION) in 2020, sourced directly from the official regulator.

91 Filings
2020 Period
2020 filings (91)
Filing Released Lang
Saniona Appoints Chief Legal Officer and Chief Technical Operations Officer to Its Executive Team
Board/Management Information
2020-12-21 English
Saniona förstärker ledningsgruppen med en Chief Legal Officer och en Chief Technical Operations Officer
Board/Management Information
2020-12-21 Swedish
Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3%
M&A Activity
2020-12-17 English
Saniona informerades idag att Novartis planerar förvärva Cadent Therapeutics, där Saniona har en ägarandel om cirka 3 procent
M&A Activity
2020-12-17 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report
2020-11-30 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report
2020-11-30 English
Saniona AB’s Nomination Committee for the Annual General Meeting 2021
Regulatory Filings
2020-11-26 English
Saniona AB:s valberedning inför årsstämman 2021
AGM Information
2020-11-26 Swedish
Saniona Reports Positive Topline Results from Tesomet Phase 2 Open-Label Extension Study in Hypothalamic Obesity
Regulatory Filings
2020-11-23 English
Saniona rapporterar positiva topline-resultat från den öppna förlängningen av Fas 2-studien med Tesomet mot hypotalamisk fetma
Earnings Release Q4 2020
2020-11-23 Swedish
Saniona renodlar sin pipeline för att fokusera på sällsynta sjukdomar – programmet för negativa allosteriska modulatorer för GABAa5 återförs från Boehringer Ingelheim
Regulatory Filings
2020-11-05 Swedish
Saniona Refines Pipeline to Focus on Rare Diseases; Regains GABAa5 Negative Allosteric Modulator Program from Boehringer Ingelheim
Regulatory Filings
2020-11-05 English
Saniona Changes Date of Interim Report for Q3 2020
Report Publication Announcement
2020-11-04 English
Saniona meddelar nytt datum för publicering av delårsrapport för Q3 2020
Report Publication Announcement
2020-11-04 Swedish
Bulletin from the extraordinary general meeting on October 23, 2020 in Saniona AB
AGM Information
2020-10-23 English
Kommuniké från extra bolagsstämma den 23 oktober 2020 i Saniona AB
AGM Information
2020-10-23 Swedish
Saniona mottar pre-IND-besked från FDA om den regulatoriska hanteringen av Tesomet för Prader-Willis syndrom (PWS) och hypotalamisk fetma (HO)
Regulatory Filings
2020-10-09 Swedish
Saniona receives pre-IND feedback from FDA on regulatory path for Tesomet in Prader-Willi Syndrome (PWS) and Hypothalamic Obesity (HO)
Regulatory Filings
2020-10-09 English
Change in numbers of shares and votes in Saniona AB (publ)
Share Issue/Capital Change
2020-09-30 English
Ändring av antalet aktier och röster i Saniona AB (publ)
Share Issue/Capital Change
2020-09-30 Swedish
Kallelse till extra bolagsstämma i Saniona AB
Proxy Solicitation & Information Statement
2020-09-29 Swedish
Notice of extraordinary general meeting in Saniona AB
Proxy Solicitation & Information Statement
2020-09-29 English
Saniona meddelar utfall i optionsinlösen
Capital/Financing Update
2020-09-23 Swedish
Saniona announces outcome of warrant exercise
Share Issue/Capital Change
2020-09-23 English
Saniona meddelar att nyttjandeperioden för teckningsoptioner av serie TO 2 inleds den 7 september 2020
Share Issue/Capital Change
2020-09-03 Swedish
Saniona announces that the exercise period of warrants of series TO 2 begins on September 7, 2020
Capital/Financing Update
2020-09-03 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-09-01 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-09-01 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-08-31 Swedish
Change in numbers of shares and votes in Saniona AB (publ)
Share Issue/Capital Change
2020-08-31 English
Ändring av antalet aktier och röster i Saniona AB (publ)
Share Issue/Capital Change
2020-08-31 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-27 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-27 English
Saniona Expands Executive Team with Appointments of Chief Financial Officer, Chief Communications Officer and Chief Human Resources Officer
Board/Management Information
2020-08-26 English
Saniona förstärker ledningsgruppen genom utnämningar av Chief Financial Officer, Chief Communications Officer och Chief Human Resources Officer
Board/Management Information
2020-08-26 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-08-20 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-08-18 Swedish
Saniona publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm
Report Publication Announcement
2020-08-11 English
Saniona offentliggör prospekt avseende upptagande till handel av nyemitterade aktier på Nasdaq Stockholm
Report Publication Announcement
2020-08-11 Swedish
Saniona successfully raises USD 65 million (approximately SEK 567 million) in a directed issue of shares
Capital/Financing Update
2020-08-10 English
Framgångsrik riktad nyemission av aktier tillför Saniona 65 miljoner USD (cirka 567 miljoner kronor)
Share Issue/Capital Change
2020-08-10 Swedish
Ändring av antalet aktier och röster i Saniona AB (publ)
Share Issue/Capital Change
2020-06-30 Swedish
Change in numbers of shares and votes in Saniona AB (publ)
Share Issue/Capital Change
2020-06-30 English
Saniona announces outcome of warrant exercise
Share Issue/Capital Change
2020-05-26 English
Saniona meddelar utfall i optionsinlösen
Share Issue/Capital Change
2020-05-26 Swedish
Saniona announces that the exercise period of warrants of series TO 1 begins May 11th, 2020
Share Issue/Capital Change
2020-05-07 English
Saniona meddelar att nyttjandeperioden för teckningsoptioner av serie TO 1 inleds den 11 maj 2020
Capital/Financing Update
2020-05-07 Swedish
BULLETIN FROM THE ANNUAL SHAREHOLDERS’ MEETING ON MAY 6, 2020 IN SANIONA AB
AGM Information
2020-05-06 English
KOMMUNIKÉ FRÅN SANIONA AB:S ÅRSSTÄMMA DEN 6 MAJ 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-06 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report
2020-05-06 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-06 English
Saniona appoints Rudolf Baumgartner, M.D., as Chief Medical Officer and Head of Clinical Development
Board/Management Information
2020-04-27 English
Saniona utser Rudolf Baumgartner till Chief Medical Officer och Head of Clinical Development
Board/Management Information
2020-04-27 Swedish
Saniona meddelar positiva topline-resultat i Fas 2-studien av Tesomet vid hypotalamisk fetma
Regulatory Filings
2020-04-22 Swedish
Saniona Reports Positive Topline Results from Phase 2 Trial of Tesomet in Hypothalamic Obesity
Regulatory Filings
2020-04-22 English
Annual Report 2019
Annual Report FY 2019
2020-04-15 Swedish
Annual Report 2020
Annual Report
2020-04-15 English
Regulatory Filings 2020
Regulatory Filings
2020-04-15 English
Notice of annual shareholders’ meeting in Saniona AB
Proxy Solicitation & Information Statement
2020-04-03 English
Kallelse till årsstämma i Saniona AB
Proxy Solicitation & Information Statement
2020-04-03 Swedish
Saniona ändrar datum för årsstämma och uppdaterar finansiell kalender
Report Publication Announcement
2020-03-31 Swedish
Saniona changes date for Annual General Meeting and updates financial calendar
Report Publication Announcement
2020-03-31 English
Saniona ingår ett andra samarbetsavtal med Boehringer Ingelheim inom schizofreni
Regulatory Filings
2020-03-26 Swedish
Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia
Regulatory Filings
2020-03-26 English
Saniona Announces Management Transition to Support Strategic Transformation
Board/Management Information
2020-03-24 English
Saniona meddelar ledningsförändring för att stödja strategisk omvandling
Board/Management Information
2020-03-24 Swedish
Saniona’s announces last day of trading in BTU and first day of trading in warrants of series TO 1, TO 2 and TO 3
Share Issue/Capital Change
2020-03-11 English
Saniona meddelar sista dag för handel i BTU samt första dag för handel i teckningsoptioner av serie TO 1, TO 2 och TO 3
Share Issue/Capital Change
2020-03-11 Swedish
Sanionas vederlagsfria företrädesemission av units övertecknad
Capital/Financing Update
2020-03-04 Swedish
Saniona’s rights issue of free-of-payment units is oversubscribed
Capital/Financing Update
2020-03-04 English
Saniona offentliggör tilläggsprospekt
Report Publication Announcement
2020-02-19 Swedish
Saniona publishes supplementary prospectus
Report Publication Announcement
2020-02-19 English
Saniona meddelar att finanschefen Thomas Feldthus kommer att lämna bolaget
Board/Management Information
2020-02-18 Swedish
Saniona announces Chief Financial Officer Thomas Feldthus will be departing the company
Board/Management Information
2020-02-18 English
Rättelse avseende ISIN-kod för BTU i prospekt
Regulatory Filings
2020-02-14 Swedish
Correction regarding ISIN code for BTU in prospectus
Regulatory Filings
2020-02-14 English
Saniona publishes prospectus relating to the rights issue of units
Report Publication Announcement
2020-02-14 English
Saniona offentliggör prospekt avseende företrädesemissionen av units
Report Publication Announcement
2020-02-14 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-10 Swedish
Bulletin from the extraordinary general meeting on February 7, 2020 in Saniona AB
Declaration of Voting Results & Voting Rights Announcements
2020-02-07 English
Kommuniké från extra bolagsstämma den 7 februari 2020 i Saniona AB
AGM Information
2020-02-07 Swedish
Annual Report 2020
Annual Report
2020-02-07 Swedish
Annual Report 2019
Annual Report FY 2019
2020-02-07 English
Change in number of shares and votes in Saniona AB (publ)
Share Issue/Capital Change
2020-01-31 English
Ändring av antalet aktier och röster i Saniona AB (publ)
Share Issue/Capital Change
2020-01-31 Swedish
Notice of extraordinary general meeting in Saniona AB
Proxy Solicitation & Information Statement
2020-01-10 English
Kallelse till extra bolagsstämma i Saniona AB
Proxy Solicitation & Information Statement
2020-01-10 Swedish
Saniona completes private placement of SEK 25 million and proposes financing of up to SEK 158 million
Capital/Financing Update
2020-01-10 English
Saniona genomför private placement om 25 MSEK och föreslår finansiering om upp till 158 MSEK
Capital/Financing Update
2020-01-10 Swedish
Saniona utser Rami Levin till vd och koncernchef
Board/Management Information
2020-01-07 Swedish
Saniona appoints CNS & rare disease veteran Rami Levin as President and Chief Executive Officer
Board/Management Information
2020-01-07 English